10 patienterne (42/ 59), ACR 50 hos 41% (24/ 59) og ACR 70 hos 31% (18/ 58) ved 48 måneder.
In study I, ACR 20 responses were observed in 71% (42/ 59) of patients, ACR 50 in 41% (24/ 59), and ACR 70 in 31% (18/ 58) at 48 months.